WEST PHARMACEUTICAL SERVICES INC 4

4 · WEST PHARMACEUTICAL SERVICES INC · Filed Feb 24, 2016

Form 4

Period: 2016-02-23

President Europe

Transactions

Sale
Common Stock
2016-02-23$59.40/sh−9,458$561,840→ 11,453.029 total
Sale
Common Stock
2016-02-24$59.66/sh−3,616$215,719→ 11,453.029 total
Award
Stock Option (Right to Buy)
2016-02-23$59.64/sh+13,012$776,036→ 13,012 total
Exercise: $59.64From: 2017-02-23Exp: 2026-02-23→ Common Stock (13,012 underlying)
Exercise/Conversion
Common Stock
2016-02-23$21.22/sh+9,458$200,699→ 20,911.029 total
Sale
Common Stock
2016-02-23$59.40/sh−6,584$391,114→ 20,911.029 total
Exercise/Conversion
Stock Option (Right to Buy)
2016-02-23$29.55/sh−6,584$194,590→ 6,584 total
Exercise: $29.55From: 2014-02-19Exp: 2023-02-19→ Common Stock (6,584 underlying)
Exercise/Conversion
Common Stock
2016-02-23$29.55/sh+6,584$194,590→ 27,495.029 total
Exercise/Conversion
Common Stock
2016-02-24$47.34/sh+3,616$171,181→ 15,069.029 total
Exercise/Conversion
Stock Option (Right to Buy)
2016-02-23$21.22/sh−9,458$200,699→ 0 total
Exercise: $21.22From: 2013-02-21Exp: 2022-02-21→ Common Stock (9,458 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2016-02-24$47.34/sh−3,616$171,181→ 7,232 total
Exercise: $47.34From: 2015-02-24Exp: 2024-02-24→ Common Stock (3,616 underlying)

Footnotes (2)

[F1]This was multiple transactions on the same date with prices in the range of $59.40 to $59.43. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
[F2]This was multiple transactions on the same date with prices in the range of $59.65 to $59.68. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.

Documents

1 file